Effect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial
Completed
- Conditions
- OsteopeniaMusculoskeletal DiseasesBone density disorders
- Registration Number
- ISRCTN85429598
- Lead Sponsor
- George Washington University (USA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 24
Inclusion Criteria
1. Women with osteopenia
2. Not taking oestrogen
3. Selective oestrogen receptor modulators
4. Bisphosphonates
5. Calcitonin
6. 3-hydroxy-3-methylglutaryl coenzyme A (HMG-coA) reductase inhibitors
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration